Howard Capital Management Group LLC Reduces Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Howard Capital Management Group LLC lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 43,512 shares of the financial services provider’s stock after selling 80 shares during the period. Howard Capital Management Group LLC owned 0.09% of iShares Biotechnology ETF worth $5,753,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the stock. BNP Paribas Financial Markets boosted its position in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after purchasing an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares in the last quarter. Aprio Wealth Management LLC bought a new position in iShares Biotechnology ETF in the 4th quarter worth approximately $18,476,000. Aristides Capital LLC purchased a new position in iShares Biotechnology ETF in the 2nd quarter valued at approximately $9,180,000. Finally, Sanctuary Advisors LLC purchased a new position in iShares Biotechnology ETF in the 2nd quarter valued at approximately $8,118,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $136.10 on Wednesday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The stock’s fifty day moving average price is $136.15 and its two-hundred day moving average price is $141.84.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.